146 related articles for article (PubMed ID: 27404046)
1. Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice.
Jin CJ; Engstler AJ; Ziegenhardt D; Bischoff SC; Trautwein C; Bergheim I
J Gastroenterol Hepatol; 2017 Mar; 32(3):708-715. PubMed ID: 27404046
[TBL] [Abstract][Full Text] [Related]
2. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH).
Jin CJ; Sellmann C; Engstler AJ; Ziegenhardt D; Bergheim I
Br J Nutr; 2015 Dec; 114(11):1745-55. PubMed ID: 26450277
[TBL] [Abstract][Full Text] [Related]
3. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
Sellmann C; Jin CJ; Engstler AJ; De Bandt JP; Bergheim I
Eur J Nutr; 2017 Dec; 56(8):2519-2527. PubMed ID: 27496089
[TBL] [Abstract][Full Text] [Related]
4. Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice.
Sellmann C; Baumann A; Brandt A; Jin CJ; Nier A; Bergheim I
J Nutr; 2017 Nov; 147(11):2041-2049. PubMed ID: 28931589
[No Abstract] [Full Text] [Related]
5. Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis.
Sellmann C; Jin CJ; Degen C; De Bandt JP; Bergheim I
J Nutr; 2015 Oct; 145(10):2280-6. PubMed ID: 26246326
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis.
Wagnerberger S; Spruss A; Kanuri G; Volynets V; Stahl C; Bischoff SC; Bergheim I
Br J Nutr; 2012 Jun; 107(12):1727-38. PubMed ID: 22018861
[TBL] [Abstract][Full Text] [Related]
7. Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis.
Sellmann C; Degen C; Jin CJ; Nier A; Engstler AJ; Hasan Alkhatib D; De Bandt JP; Bergheim I
Amino Acids; 2017 Jul; 49(7):1215-1225. PubMed ID: 28434046
[TBL] [Abstract][Full Text] [Related]
8. Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice.
Uesugi T; Froh M; Arteel GE; Bradford BU; Wheeler MD; Gäbele E; Isayama F; Thurman RG
J Immunol; 2002 Mar; 168(6):2963-9. PubMed ID: 11884468
[TBL] [Abstract][Full Text] [Related]
9. Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease.
Kanuri G; Ladurner R; Skibovskaya J; Spruss A; Königsrainer A; Bischoff SC; Bergheim I
Liver Int; 2015 Feb; 35(2):562-8. PubMed ID: 24351080
[TBL] [Abstract][Full Text] [Related]
10. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I
J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700
[TBL] [Abstract][Full Text] [Related]
11. Aging-related liver degeneration is associated with increased bacterial endotoxin and lipopolysaccharide binding protein levels.
Jin CJ; Baumann A; Brandt A; Engstler AJ; Nier A; Hege M; Schmeer C; Kehm R; Höhn A; Grune T; Witte OW; Bergheim I
Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G736-G747. PubMed ID: 32090603
[TBL] [Abstract][Full Text] [Related]
12. fat-1 mice prevent high-fat plus high-sugar diet-induced non-alcoholic fatty liver disease.
Guo XF; Gao JL; Li JM; Li D
Food Funct; 2017 Nov; 8(11):4053-4061. PubMed ID: 28972610
[TBL] [Abstract][Full Text] [Related]
13. GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease.
Baumann A; Burger K; Brandt A; Staltner R; Jung F; Rajcic D; Lorenzo Pisarello MJ; Bergheim I
Metabolism; 2022 Aug; 133():155233. PubMed ID: 35654114
[TBL] [Abstract][Full Text] [Related]
14. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.
Baumann A; Jin CJ; Brandt A; Sellmann C; Nier A; Burkard M; Venturelli S; Bergheim I
Nutrients; 2020 Mar; 12(4):. PubMed ID: 32235497
[TBL] [Abstract][Full Text] [Related]
15. CD14 and lipopolysaccharide binding protein expression in a rat model of alcoholic liver disease.
Su GL; Rahemtulla A; Thomas P; Klein RD; Wang SC; Nanji AA
Am J Pathol; 1998 Mar; 152(3):841-9. PubMed ID: 9502426
[TBL] [Abstract][Full Text] [Related]
16. Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function.
Brandt A; Nier A; Jin CJ; Baumann A; Jung F; Ribas V; García-Ruiz C; Fernández-Checa JC; Bergheim I
Redox Biol; 2019 Feb; 21():101092. PubMed ID: 30605883
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice.
Liu J; Zhuang ZJ; Bian DX; Ma XJ; Xun YH; Yang WJ; Luo Y; Liu YL; Jia L; Wang Y; Zhu ML; Ye DW; Zhou G; Lou GQ; Shi JP
Clin Exp Pharmacol Physiol; 2014 Jul; 41(7):482-8. PubMed ID: 24739055
[TBL] [Abstract][Full Text] [Related]
18. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver.
Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP
Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520
[TBL] [Abstract][Full Text] [Related]
19. Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.
Spruss A; Henkel J; Kanuri G; Blank D; Püschel GP; Bischoff SC; Bergheim I
Mol Med; 2012 Dec; 18(1):1346-55. PubMed ID: 22952059
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
Spruss A; Kanuri G; Wagnerberger S; Haub S; Bischoff SC; Bergheim I
Hepatology; 2009 Oct; 50(4):1094-104. PubMed ID: 19637282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
